These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 3885020)
41. Enhancement of the mutagenicity of carcinogenic arylamines by ethinyl estradiol. Purdy RH; Marshall MV Carcinogenesis; 1984 Dec; 5(12):1709-15. PubMed ID: 6499122 [TBL] [Abstract][Full Text] [Related]
42. The effect of paraquat on the mutagenicity of benzo(a)pyrene. Wei CI; Allen K; Misra HP J Appl Toxicol; 1985 Oct; 5(5):315-9. PubMed ID: 3902944 [TBL] [Abstract][Full Text] [Related]
43. Mutagenic, cytotoxic, and teratogenic effects of 2-acetylaminofluorene and reactive metabolites in vitro. Faustman-Watts EM; Yang HY; Namkung MJ; Greenaway JC; Fantel AG; Juchau MR Teratog Carcinog Mutagen; 1984; 4(3):273-83. PubMed ID: 6147026 [TBL] [Abstract][Full Text] [Related]
44. In vitro effects of N-acetylcysteine on the mutagenicity of direct-acting compounds and procarcinogens. De Flora S; Bennicelli C; Zanacchi P; Camoirano A; Morelli A; De Flora A Carcinogenesis; 1984 Apr; 5(4):505-10. PubMed ID: 6368036 [TBL] [Abstract][Full Text] [Related]
45. Selenium inhibition of benzo[a]pyrene, 3-methylcholanthrene, and 3-methylcholanthrylene mutagenicity in Salmonella typhimurium strains TA98 and TA100. Prasanna P; Jacobs MM; Yang SK Mutat Res; 1987 Feb; 190(2):101-5. PubMed ID: 3547113 [TBL] [Abstract][Full Text] [Related]
46. Sulfation in the metabolism and mutagenicity of N-hydroxy-2-fluorenylacetamide. Hinson JA; Andrews LS; Gillette JR Natl Cancer Inst Monogr; 1981 Dec; (58):113-6. PubMed ID: 6176868 [No Abstract] [Full Text] [Related]
47. Metabolic activation of procarcinogens by subcellular enzyme fractions in the C3H 10T1/2 and BALB/c 3T3 cell transformation systems. Schechtman LM IARC Sci Publ; 1985; 67():137-62. PubMed ID: 3913640 [No Abstract] [Full Text] [Related]
48. The influence of automobile exhausts on mutagenicity of soils: contamination with, fractionation, separation, and preliminary identification of mutagens in the Salmonella/reversion assay and effects of solvent fractions on the sister-chromatid exchanges in human lymphocyte cultures and in the in vivo mouse bone marrow micronucleus assay. Wesp HF; Tang X; Edenharder R Mutat Res; 2000 Dec; 472(1-2):1-21. PubMed ID: 11113694 [TBL] [Abstract][Full Text] [Related]
49. Deactivation of sodium azide in the Salmonella/microsome test. Dierickx PJ Bull Environ Contam Toxicol; 1979 Jul; 22(4-5):660-5. PubMed ID: 385084 [No Abstract] [Full Text] [Related]
50. Studies on antimutagenic effects of guava (Psidium guajava) in Salmonella typhimurium. Grover IS; Bala S Mutat Res; 1993 Jun; 300(1):1-3. PubMed ID: 7683763 [TBL] [Abstract][Full Text] [Related]
51. The importance of 2-aminofluorene in the mutagenic activation of 2-acetylaminofluorene. Robertson IG Mutat Res; 1986 Nov; 175(3):153-7. PubMed ID: 3534560 [TBL] [Abstract][Full Text] [Related]
52. Antimutagenic and anti-oxidant activities of the non-steroidal anti-inflammatory drug celecoxib. Ajith T; Subin JP; Jacob J; Sanjay PS; Babitha NV Clin Exp Pharmacol Physiol; 2005 Oct; 32(10):888-93. PubMed ID: 16173952 [TBL] [Abstract][Full Text] [Related]
53. Possible mechanisms of antimutagens by various teas as judged by their effects on mutagenesis by 2-amino-3-methylimidazo[4,5-f]quinoline and benzo[a]pyrene. Chen HY; Yen GC Mutat Res; 1997 Sep; 393(1-2):115-22. PubMed ID: 9357568 [TBL] [Abstract][Full Text] [Related]
54. Antimutagenic effects of taurine in a bacterial assay system. Laidlaw SA; Dietrich MF; Lamtenzan MP; Vargas HI; Block JB; Kopple JD Cancer Res; 1989 Dec; 49(23):6600-4. PubMed ID: 2479467 [TBL] [Abstract][Full Text] [Related]
55. Relationship between vitamin A dietary intake and mutagenic activity of some chemical carcinogens. Cassand P; Leveque F; Decoudu S; Narbonne JF Food Addit Contam; 1990; 7 Suppl 1():S58-9. PubMed ID: 2124552 [No Abstract] [Full Text] [Related]
56. Further studies on the comutagenic activity of cigarette smoke condensate. Crebelli R; Conti L; Fuselli S; Leopardi P; Zijno A; Carere A Mutat Res; 1991 Jan; 259(1):29-36. PubMed ID: 1988821 [TBL] [Abstract][Full Text] [Related]
57. Alteration of the ability of liver microsomes to activate N-2-fluorenylacetamide to a mutagen of Salmonella typhimurium during hepatocarcinogenesis. Stout DL; Becker FF Cancer Res; 1978 Aug; 38(8):2274-8. PubMed ID: 208764 [No Abstract] [Full Text] [Related]
58. Genotoxicity studies with mineral oils; effects of oils on the microbial mutagenicity of precursor mutagens and genotoxic metabolites. Watson WP; Brooks TM; Gonzalez LP; Wright AS Mutat Res; 1985 Apr; 149(2):159-70. PubMed ID: 3920514 [TBL] [Abstract][Full Text] [Related]
59. UV-irradiation potentiates the antimutagenicity of p-aminobenzoic and p-aminosalicylic acids in Salmonella typhimurium. Gichner T; Baburek I; Velemínský J; Kappas A Mutat Res; 1991 Jul; 249(1):119-23. PubMed ID: 2067527 [TBL] [Abstract][Full Text] [Related]
60. Mutagenicity of the atmospheric transformation products 2-nitrofluoranthene and 2-nitrodibenzopyranone in Salmonella and human cell forward mutation assays. Busby WF; Smith H; Crespi CL; Penman BW; Lafleur AL Mutat Res; 1997 Mar; 389(2-3):261-70. PubMed ID: 9093392 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]